M&A | Partnerships

December 29, 2020

Collagen Matrix Acquires Resorbable Synthetic Bone Grafts

Collagen Matrix Acquires Resorbable Synthetic Bone Grafts
The transaction includes GUIDOR bone graft substitutes known as easy-graft and calc-i-oss, and builds on the company's strategy to expand its technologies.
October 5, 2020

Bone Therapeutics Collaborates on ALLOB in Asia

Bone Therapeutics Collaborates on ALLOB in Asia
Bone Therapeutics granted an exclusive license to develop and collaborate on ALLOB in Greater China and a number of other major Asian countries.
September 30, 2020

Seikagaku Signs Marketing Agreement for OA Treatment

Seikagaku Signs Marketing Agreement for OA Treatment
Eisai and Seikagaku will co-develop and market the SI-613 sodium hyaluronate therapeutic agent in South Korea for the treatment of knee osteoarthritis.
September 2, 2020

Royal Biologics Acquires FIBRINET Platelet-Rich Fibrin Matrix

Royal Biologics Acquires FIBRINET Platelet-Rich Fibrin Matrix
Fibrinet enables safe and rapid preparation of Platelet-Rich Fibrin Membrane and Platelet-Rich Fibrin Gel from a small sample of blood at the point of care.